Screener
Maravai LifeSciences Holdings, Inc. MRVI Cygnus — Cost of revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001823239-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | $51,442 | $47,397 | $117,279 | $94,247 |
| Cost of revenue | 30,792 | 39,629 | 62,928 | 78,754 |
| Gross profit | 20,650 | 7,768 | 54,351 | 15,493 |
| Operating expenses: | ||||
| Selling, general and administrative | 32,070 | 38,715 | 61,162 | 78,279 |
| Research and development | 3,702 | 4,882 | 7,591 | 9,770 |
| Goodwill impairment | — | 30,449 | — | 42,884 |
| Restructuring | (33) | — | 2,845 | — |
Item 1. Financial Statements
FAQ
- What is Maravai LifeSciences Holdings, Inc.'s cygnus — cost of revenue?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — cost of revenue of $2.82M in Q2 2026.
- How has Maravai LifeSciences Holdings, Inc.'s cygnus — cost of revenue changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s cygnus — cost of revenue decreased by 6.0% year-over-year, from $3M to $2.82M.
- What does cygnus — cost of revenue mean?
- Represents the direct costs incurred to produce and deliver the products and services sold by the Biologics Safety Testing segment. This includes raw materials, direct labor, and manufacturing overheads directly tied to revenue generation. It is a key metric for evaluating the segment's gross margin and production efficiency.
Ask your AI about Maravai LifeSciences Holdings, Inc.'s cygnus — cost of revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude